Oral formulation of Wnt inhibitor complex reduces inflammation and fibrosis in intraperitoneal implants in vivo.
de Castro Santos AL, da Silva NJA, Viana CTR, Dos Santos LCC, da Silva GHC, Scalzo Júnior SRA, Costa PAC, da Silva WN, de Jesus ICG, Birbrair A, de Magalhães MTQ, Frézard F, Guatimosim S, Haley RM, Mitchell MJ, Andrade SP, Campos PP, Guimaraes PPG.
de Castro Santos AL, et al. Among authors: de jesus icg.
Drug Deliv Transl Res. 2023 May;13(5):1420-1435. doi: 10.1007/s13346-023-01303-0. Epub 2023 Feb 7.
Drug Deliv Transl Res. 2023.
PMID: 36749480